Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Authorized Generic Drugs, Price Competition, And Consumers’ Welfare

4 references·7 citing·37 second hop

FromToDepth

this work references cited by second hop

References

1991Entry and Competition in Concentrated Markets1,465 cited
1991Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry399 cited
2005Generic Drug Industry Dynamics312 cited
2000Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry226 cited

Cited by

2011When Do Generics Challenge Drug Patents?100 cited
2009Balancing Innovation and Access: Patent Challenges Tip the Scales96 cited
2011Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry96 cited
2010Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century After the 1984 Waxman-Hatch Legislation92 cited
2008Follow-on biologics: data exclusivity and the balance between innovation and competition89 cited
2018The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review86 cited
2013Development of the generic drug industry in the US after the Hatch-Waxman Act of 198474 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work